GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $9,022,000 | +20881.4% | 377,505 | +3540.4% | 0.06% | – |
| Q1 2020 | $43,000 | -14.0% | 10,370 | 0.0% | 0.00% | – |
| Q4 2019 | $50,000 | -20.6% | 10,370 | 0.0% | 0.00% | – |
| Q3 2019 | $63,000 | -6.0% | 10,370 | 0.0% | 0.00% | – |
| Q2 2019 | $67,000 | -9.5% | 10,370 | 0.0% | 0.00% | – |
| Q1 2019 | $74,000 | +48.0% | 10,370 | 0.0% | 0.00% | – |
| Q4 2018 | $50,000 | -34.2% | 10,370 | 0.0% | 0.00% | – |
| Q3 2018 | $76,000 | +15.2% | 10,370 | 0.0% | 0.00% | – |
| Q2 2018 | $66,000 | +17.9% | 10,370 | 0.0% | 0.00% | – |
| Q1 2018 | $56,000 | – | 10,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|